DLL4 and acute lymphoblastic leukemia: CircPVT1 was found to participate in T‐ALL progression through miR‐30e/DLL4 axis,50 and facilitate the proliferation and invasion via miR‐125b modulation of NF‐κB in ALL,51 representing a promising target for T‐ALL therapy.